Cell-free circulating DNA Integrity based on peripheral blood as a biomarker for diagnosis of cancer: A systematic review
Cancer Epidemiology, Biomarkers & Prevention Aug 30, 2017
Cheng J, et al. – The diagnostic performance of cell–free DNA integrity (cfDI) was investigated in cancer. Although the sensitivity and area under the curve (AUC) were relatively high, cfDI was found to be controversial as a blood–based biomarker of cancers.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
